Title: How Do Drugs Affect the Nervous System?
1How Do Drugs Affect the Nervous System? .
Understanding Neural Transmission
Drugs act on Neurons and their communication with
other cells
2Beauty in the nervous system?
3(No Transcript)
4The Basis of the Nervous System
- Neurons Single cell unit of the nervous system
- 10 billion in the brain alone
- Receives, processes and transmits information
- Each neuron in the brain received signals from
thousands of other neurons.
5In most respects the neuron is like other cells
of our body
6But is different in that it can produce
electrical impulses near its cell body region
7A Classical Study showing the RESTING MEMBRANE
POTENTIAL (RMP) of the Neuron
8The RMP
- The RMP for a typical neuron is about -70mv
9Threshold voltage change (depolarization)
triggers the Action Potential
Hyperpolarization- in the case of neurons means
to make the RMP more negative. Depolarization
means to make the RMP more positive
10Once triggered, the AP is all or none, and
one-way.
The AP will travel to the terminal and there
initiate a chemical event
11The Neuronal communication process can be thought
of as an electro-chemical event.
- Most Psychoactive drugs directly affect the
chemical portion of the process
12The Neuronal communication process can be thought
of as an electro-chemical event
- How is the electric signal produced?
- How is the Chemical event produced?
13The Neuron is Like a little battery
14Ions are responsible for the charge of a neuron
Cations Anions-
15The forces of Diffusion Concentration Gradients
16Diffusion also occurs across electrostatic
gradients
17The neural membrane is a semi-permeable membrane
18The Neurons membrane separates the different ions
19The membrane controls diffusion
20By opening or closingIon channels
21If ion channels are open diffusion across
concentration and electrostatic gradients will
occur
22(No Transcript)
23Triggering the release of RMP energy
- How does threshold depolarization trigger a
dynamic response? - Changes membrane permeability
- Activating/opening ion channels
- -Voltage-gated Na ion channels
- Open only when a critical level of depol occurs
- Other ion channels then become involved
24(No Transcript)
25Action Potential at the Terminals
26Terminal Boutons end adjacent to other cells
The Synapse- a very small space between the
boutons of one neuron and typically the dendrites
of another.
27The Synapse PRESYNAPTIC and POSTSYNAPTIC
processes
Any process associated with the terminal bouton
of Neuron A are considered to be presynaptic
processes. Any process associated with effects
of NT release on neuron B are considered
postsynaptic processes.
28PRESYNAPTIC Exocytosis
The Action Potential leads to release of
Neurotransmitter substance (exocytosis) into the
synapse.
29Synaptic release of Neurotransmitter substances
may in turn affect postsynaptic neurons
30Neurotransmitters
There are many different Neurotransmitter
Families.
Different NTs are found in different pathways and
are involved in different functions/ or different
components of functions.
31Some Classical NTs, terminology and postsynaptic
effects
- NTs Terminology
Post synaptic effects - Acetylcholine/ACH Cholinergic /-
- Serotonin/5-HT serotonergic /-
- GABA (gamma-amino-butyric acid) GABA-ergic -
- Glutamate/Glu Glutamatergic
- Norpinephrine /NE Adrenergic /-
- Dopamine /DA Dopaminergic /-
- Enkephalin/Endorphin /-
- Many other neurotransmitters are derived from
precursor proteins, the so-called peptide
neurotransmitters. As many as 50 different
peptides have been shown to exert their effects
on neural cell function.
32Some Basic Functions Associated with Different NT
Families
- Acetylcholine-(ACH,cholinergic)
-Skeletal Muscle control -Parasympathetic
Autonomic functions -Thirst -Memory Alzheimers
disease
33Pattern of projection pathways associated with
acetylcholine brain nuclei ( cholinergic systems
34Norepinephrine- (NE, noradrenergic, a
catecholamine)
- Sympathetic ANS functions
- hunger
- mood
35Noradrenergic system (Norepinephrine)
36Dopamine- ( DA, dopaminergic, a catecholamine)
- movement (Parkinsons disease)
- wanting
- mood
- attention, and learning.
- Dopamine excess may be involved in Schizophrenia.
37Dopamine
38Parkinsons Disease
- Parkinsons disease, dopamine and the substantia
nigra
39(No Transcript)
40Parkinsons disease and MPTP
- 1980s designer drugs MPPP/MPTPP and the case
of the frozen addicts -
41Serotonin ( 5-HT, serotonergic, an indolamine)
42Serotonergic System (Serotonin)
43Multiple types of synapses
- Multiple patterns of connectivity
- Axodendritic
- Axoaxonic
- Axosomatic
- Dendrodendritic
6.1
44Endorphins
- Modulate the experience of pain
- Involved in breathing and heart rate, cough
reflex, nausea and vomiting - Involved in feelings of euphoria and reward
45GABA
- Most prevalent inhibitory neurotransmitter in the
brain - GABA secreted by local interneurons all over
the brain. - Implicated in relaxation/anti-anxiety
46Glutamate
- Most prevalent excitatory NT.
- Involved in many brain circuits, but especially
important in the formation of memories. - Brain injury is associated with release of Glut.
In high concentration, which in turn may be toxic
to neurons.
47Neurotransmitters bind to receptor sites to
produce postsynaptic effects
48NT-Receptor Specificity
A given NT substance will only activate specific
receptor proteins, and can not activate receptors
for other NTs
- Lock Key Model
- NT key
- Receptor lock
Activation of a receptor will lead to either
Excitation or Inhibition.
49Two General Types of Receptor
- Ionotropic receptors the receptor is an ion
channel - Metabotropic receptors Activation of the
receptor will in turn activate a second
messenger chemical that may open or close ion
channels
50IONOTROPIC RECEPTORS-
51Metabotropic Receptors
52How can one NT sometimes produce excitatory
postsynaptic effects and in other cases produce
inhibitory postsynaptic effects?
- NTs Terminology
Post synaptic effects - Acetylcholine/ACH Cholinergic /-
- Serotonin/5-HT serotonergic /-
- GABA (gamma-amino-butyric acid) GABA-ergic -
- Glutamate/Glu Glutamatergic
- Norpinephrine /NE Adrenergic /-
- Dopamine /DA Dopaminergic /-
- Enkephalin/Endorphin /-
- Many other neurotransmitters are derived from
precursor proteins, the so-called peptide
neurotransmitters. As many as 50 different
peptides have been shown to exert their effects
on neural cell function.
53One Neurotransmitter may activate any of a
family of receptor subtypes
ACH in the ANS can activate the Muscarinic ACH
receptor (mACH), a metabotropic receptor type.
Activation of the mACHr leads to an inhibitory
response.
ACH release in the somatic branch of the PNS
activates the Nicotinic ACH receptor (nACHr).
An ionotropic receptor type.
Activation of the nACHr leads to an excitatory
response.
54Effects depend on receptor subtype
55Deactivation of NTs
- Enzyme Breakdown
- Reuptake
56NT-receptor interactions must stop!Enzymatic
degradation
ACH is broken apart in the synapse by the enzyme
acetylcholine-esterase (ACHE).
The importance of the termination of NT-receptor
interactions is critical for normal function..
57Nerve Gases and their typical mechanism of
action
58Most nerve gases produce their effects by
blocking the breakdown of ACH ( by binding to and
blocking the action of ACHE).
59Effects of Nerve gas exposure
The blockade of ACHE leads to too much ACH in ACH
synapses, and exaggerated postsynaptic effects.
Neuromuscular Effects Autonomic NervousSystem Effects Central NervousSystem Effects
Twitching Weakness Paralysis Respiratory failure Reduced Vision Small pupil size Drooling Sweating Diarrhea Nausea Abdominal pain Vomiting Headache Convulsions Coma Respiratory arrest Confusion Slurred speech Depression Respiratory depression
60Monoamine Oxidase MAO
- MAO acts to break down NE and 5-HT
61Reuptake
The serotonin transporter enzyme is responsible
for terminating the effects of 5-HT in
serotonergic synapses
62Of Interest??? Selective serotonin reuptake
inhibitors- Bind to and reduce the effectiveness
of the 5-HT transporter
SSRIs approved to treat depression, with their
generic, or chemical, names followed by available
brand names in parentheses Citalopram (Celexa)
Escitalopram (Lexapro) Fluoxetine (Prozac,
Prozac Weekly) Paroxetine (Paxil, Paxil CR,
Pexeva) Sertraline (Zoloft) These medications
may also be used to treat conditions other than
depression. Side effects of SSRIs All SSRIs
have the same general mechanism of action and
side effects. However, individual SSRIs have some
different pharmacological characteristics. That
means you may respond differently to certain
SSRIs or have different side effects with
different SSRIs.
63Of interest??SSRI possible side-effects
Side effects of SSRIs include Nausea Sexual
dysfunction, including reduced desire or orgasm
difficulties Dry mouth Headache Diarrhea
Nervousness Rash Agitation Restlessness
Increased sweating Weight gain Drowsiness
Insomnia
64How Do Drugs affect the nervous system?
Ligand a fancy term for substances that bind to
receptors -neurotransmitters -drugs
65In general we classify drug effects into 2 basic
types
Drugs may act as Agonists- the Ligand may mimic
the NT and activate the receptor, or facilitate
the natural effects of the NT in indirect ways
- Drugs may act as Antagonists
- The ligand may block the receptor, or in indirect
ways decrease the effect of the NT at its
receptor.
66Drug Action
- Direct Agonist Ligand Activates receptor
- Direct Antagonist Ligand Blocks receptor
- Indirect agonism or antagonism
- Alters enzyme activity
- Blocks reuptake
- Etc
67Forms of Drug Action at the Synapse
- Ways to agonize
- Stimulate release
- Receptor binding
- Inhibition of reuptake
- Inhibition of deactivation
- Promote synthesis
- Ways antagonize
- Block release
- Receptor blocker
- Prevent synthesis
8. Autoreceptors
68Drugs may agonize or antagonize neural
transmission in many indirect ways.
69Acetylcholine
Agonists
Nicotine Physostigmine
Antagonists
Muscarinic receptor - Atropine Nicotinic
receptor - Curare
70Dopamine
- Cocaine
- dopamine reuptake inhibitor
- Amphetamine
- increases DA release
- Antipsychotics
- block post-synaptic dopamine receptor
71Cocaine acts as a monoamine agonist by blocking
the reuptake transporter enzyme
72Serotonin
- Selective-serotonin reuptake inhibitors (SSRIs)
used to treat depression
73GABA
- Valium, Xanax, Ativan
- Act as GABA agonists
- GHB, Rohypnol
- GABA agonist
74Chronic Effects
- Depletion of transmitters
- Alter transmitter production
- Alter receptor density
- Affect neurogenesis
75Agonist/Antagonist
- Agonist
- Drug binds and induces full pharmacological
effect - Partial Agonist
- Drug binds and exerts only a partial effect
- Competitive Antagonist
- Binds to same receptor as agonist
- Reduces the effect
- Effect can be overcome by sufficient dose
- Noncompetitive Antagonist
- Binds in other ways, but disrupts agonist binding
- Reduces the effect
- Effect can not be overcome by sufficient dose
76Drug Interaction Terms
- Competitive antagonist
- competes for same receptor site
- lt affinity of NT
- Noncompetitive
- same binding site, gtgt affinity than NT
- or different binding site or receptor
77Neurotransmission